Cargando…
COVID-19 vaccines versus pediatric hospitalization
Vaccine effectiveness of BNT162b2 and CoronaVac against COVID-19-associated hospitalization and moderate-to-severe disease due to SARS-CoV-2 Omicron BA.2 is studied from the 1.36 million doses administered to 766,601 of 953,400 children aged 3–11 years and adolescents aged 12–18 years in Hong Kong a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868379/ https://www.ncbi.nlm.nih.gov/pubmed/36801010 http://dx.doi.org/10.1016/j.xcrm.2023.100936 |
_version_ | 1784876522919690240 |
---|---|
author | Rosa Duque, Jaime S. Leung, Daniel Yip, Ka Man Lee, Derek H.L. So, Hung-kwan Wong, Wilfred H.S. Lau, Yu Lung |
author_facet | Rosa Duque, Jaime S. Leung, Daniel Yip, Ka Man Lee, Derek H.L. So, Hung-kwan Wong, Wilfred H.S. Lau, Yu Lung |
author_sort | Rosa Duque, Jaime S. |
collection | PubMed |
description | Vaccine effectiveness of BNT162b2 and CoronaVac against COVID-19-associated hospitalization and moderate-to-severe disease due to SARS-CoV-2 Omicron BA.2 is studied from the 1.36 million doses administered to 766,601 of 953,400 children aged 3–11 years and adolescents aged 12–18 years in Hong Kong as of April 2022. These vaccines confer substantial protection. |
format | Online Article Text |
id | pubmed-9868379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98683792023-01-23 COVID-19 vaccines versus pediatric hospitalization Rosa Duque, Jaime S. Leung, Daniel Yip, Ka Man Lee, Derek H.L. So, Hung-kwan Wong, Wilfred H.S. Lau, Yu Lung Cell Rep Med Commentary Vaccine effectiveness of BNT162b2 and CoronaVac against COVID-19-associated hospitalization and moderate-to-severe disease due to SARS-CoV-2 Omicron BA.2 is studied from the 1.36 million doses administered to 766,601 of 953,400 children aged 3–11 years and adolescents aged 12–18 years in Hong Kong as of April 2022. These vaccines confer substantial protection. Elsevier 2023-01-23 /pmc/articles/PMC9868379/ /pubmed/36801010 http://dx.doi.org/10.1016/j.xcrm.2023.100936 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Rosa Duque, Jaime S. Leung, Daniel Yip, Ka Man Lee, Derek H.L. So, Hung-kwan Wong, Wilfred H.S. Lau, Yu Lung COVID-19 vaccines versus pediatric hospitalization |
title | COVID-19 vaccines versus pediatric hospitalization |
title_full | COVID-19 vaccines versus pediatric hospitalization |
title_fullStr | COVID-19 vaccines versus pediatric hospitalization |
title_full_unstemmed | COVID-19 vaccines versus pediatric hospitalization |
title_short | COVID-19 vaccines versus pediatric hospitalization |
title_sort | covid-19 vaccines versus pediatric hospitalization |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868379/ https://www.ncbi.nlm.nih.gov/pubmed/36801010 http://dx.doi.org/10.1016/j.xcrm.2023.100936 |
work_keys_str_mv | AT rosaduquejaimes covid19vaccinesversuspediatrichospitalization AT leungdaniel covid19vaccinesversuspediatrichospitalization AT yipkaman covid19vaccinesversuspediatrichospitalization AT leederekhl covid19vaccinesversuspediatrichospitalization AT sohungkwan covid19vaccinesversuspediatrichospitalization AT wongwilfredhs covid19vaccinesversuspediatrichospitalization AT lauyulung covid19vaccinesversuspediatrichospitalization |